Published in AIDS Weekly, November 18th, 1996
After reviewing the history and present status of HIV vaccine research, Duke University AIDS Center researcher Barton F. Haynes concluded that a successful AIDS vaccine will have to account for extensive genetic variability not only in the virus, but also in human populations.
Haynes's review-cum-manifesto appeared in the journal The Lancet ("HIV Vaccines: Where We Are and Where We Are Going," Lancet, 1996;348:933-37).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.